One of the drugs used in suppressing immune reactions associated with transplants has proven to have another use--extending lifespan in mice. As noted in Discover, "Laboratory mice who were given an immunosuppresant drug called rapamycin lived between 9 and 14 percent longer than mice who didn’t take the drug, according to a study in Nature. The drug, which was developed from bacteria found in Easter Island’s dirt, is the first pharmacological agent shown to enhance longevity in a mammal [Technology Review]. Even more remarkable, the mice weren’t given the drug until late middle age, showing rapamycin had effects even when taken later in life."
This contest in June passed unnoticed--entrepreneurs competed for a $10,000 prize for new products and services to help seniors: "The aging "have unmet needs that might be passed over by inventors," said Ruley Peh co-founder of the company that is based at Stanford University. "We're bringing technology to places and people where we think we can make a difference."
"Startups that target the aging are getting better, said Mary Furlong, a consultant and Santa Clara University business professor who started the competition - called the Silicon Valley Boomer Venture Summit - five years ago. Data about aging are improving, too.
Yet most businesses are still slow to the market, preferring instead to chase youth even though many Boomers try to defy their inevitable physical deterioration by living active lives."
"Other finalists for this year's $10,000 prize included companies that have improved hearing aids, chemotherapy, abdominal surgery and treatment for infections.
There were also five finalists for a $1,000 elevator-pitch prize, several revolving around technology to help seniors stay in touch with family, cut costs or find the best health care when they retire to foreign countries.
The winner, Live at Home Longer, has technology to help seniors stay independent."
Comments